Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
17.60
+0.82 (4.89%)
At close: Jun 9, 2025, 4:00 PM
18.03
+0.43 (2.44%)
After-hours: Jun 9, 2025, 4:00 PM EDT
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $959.08 million as of June 9, 2025. Its market cap has decreased by -13.41% in one year.
Market Cap
959.08M
Enterprise Value
663.67M
1-Year Change
-13.41%
Ranking
Category
Stock Price
$17.60
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $959.08M, an increase of 50.61%. That is a compound annual growth rate of 9.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 914.39M | -12.05% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |